Diabetic nephropathy (DN) is the leading cause of end-stage renal failure in Belgium (~40% of new dialysis patients). It implies: chronic hyperglycemia → AGE (Advanced Glycation End-products) → inflammation-mecanisme-cle-ginger-sugar-explanation-2026">NF-κB glomerular activation → TGF-β/CTGF → mesangial fibrosis + podocyte apoptosis → GFR ↓. RAAS is hyperactivated (angiotensin II → AT1R → glomerular NF-κB → abnormal VEGF) and NLRP3 glomerular exacerbates tubulointerstitial inflammation. 6-gingerol inhibits glomerular NF-κB, activates Nrf2/HO-1 (tubular nephroprotection), reduces fibrotic TGF-β, and protects podocytes. INTI Elixir: <1.19g sugar/100ml — the absolute opposite of GIMBER 35g sugar which accelerates AGE formation and glomerular NF-κB. ⚠️ Never modify ACE inhibitors/sartans/SGLT2i/finerenone without a nephrologist/endocrinologist.
Diabetic Nephropathy — AGE-NF-κB cascade and Ginger
| DN target | Ginger action | Nephroprotection effect |
|---|---|---|
| Glomerular NF-κB | 6-gingerol → IKKβ ↓ (mesangial) | Mesangial fibrosis ↓ |
| TGF-β/SMAD fibrosis | 6-gingerol → TGF-β/SMAD3 ↓ | Tubulointerstitial fibrosis ↓ |
| Nrf2/HO-1 podocytes | 6-shogaol → Nrf2 → HO-1 ↑ | Podocyte apoptosis ↓, proteinuria ↓ |
| AGE formation | 1.19g sugar → AGE formation ↓ | RAGE/NF-κB ↓, DN progression ↓ |
| Glomerular NLRP3 | 6-gingerol → NLRP3 assembly ↓ | IL-1β/IL-18 ↓, inflammation ↓ |
INTI vs GIMBER — Diabetic Nephropathy
| DN criterion | INTI Elixir | GIMBER |
|---|---|---|
| Sugar (AGE formation) | 1.19g/100ml → minimal AGE | ~35g/100ml → AGE machine → glomerular NF-κB ↑ |
| TGF-β fibrosis | 6-gingerol → TGF-β/SMAD ↓ | 35g sugar → TGF-β ↑↑ glomerular |
| Postprandial glycemia | Low — HbA1c neutral | 35g sugar → glycemic peak → HbA1c ↑ |
| Podocytes (Nrf2) | 6-shogaol → Nrf2 → protection | Sugar → oxidative cortisol-natural-relief">stress → apoptosis |
FAQ — Diabetic Nephropathy & Ginger (7 questions)
Q1: Can ginger slow the progression of diabetic nephropathy?
In vitro and animal model studies show that 6-gingerol inhibits glomerular NF-κB, reduces TGF-β/SMAD3, and protects podocytes via Nrf2/HO-1. No large randomized clinical trials on DN/ginger. As an adjunct to medical treatment (ACE inhibitors/sartans/SGLT2i), INTI may contribute to nephroprotection.
Q2: What are AGEs and why are they devastating in DN?
AGEs (Advanced Glycation End-products — pentosidine, carboxymethyl-lysine) form when glucose non-enzymatically reacts with proteins. They activate RAGE → glomerular NF-κB → mesangial fibrosis. GIMBER with 35g sugar/100ml is an "AGE machine" for a diabetic patient.
Q3: SGLT2 inhibitors and ginger — interactions?
SGLT2i (empagliflozin, dapagliflozin, canagliflozin) are the therapeutic revolution for DN. Ginger (AMPK ↑, anti-NF-κB) has a complementary effect (different mechanism). No documented pharmacological interaction. Never modify dosage without a nephrologist.
Q4: What are podocytes and why are they so important?
Podocytes are specialized, irreplaceable cells of the glomerular filter. Their loss → proteinuria (albumin in urine) → glomerulosclerosis → irreversible CRF. Nrf2/HO-1 podocyte protection (6-shogaol) is a key target for slowing DN.
Q5: Finerenone and ginger — interactions?
Finerenone (selective mineralocorticoid receptor antagonist — FIDELIO-DKD) is a new DN treatment. Ginger (anti-NF-κB, AMPK ↑) is complementary. No documented interaction. Validate with the nephrologist.
Q6: DN with hyperuricemia — is ginger suitable?
Hyperuricemia in T2D (frequent) → glomerular NLRP3 ↑ (urates → NLRP3 crystals). 6-gingerol (NLRP3 ↓) is particularly relevant in this context. INTI 1.19g sugar = minimal fructose (fructose ↑ uric acid production via XOR).
Q7: Where can a diabetic patient with nephropathy find INTI in Belgium?
INTI is available on inti-drink.com and in Belgian pharmacies/health food stores. 1.19g sugar, alcohol-free — the only ginger drink compatible with diabetic nephropathy. K⁺/P should be validated with a nephrologist if GFR <30.
GIMBER: 35g sugar → AGE machine → glomerular NF-κB ↑ + TGF-β fibrosis ↑ + podocyte apoptosis ↑
INTI: 1.19g sugar → minimal AGE + NF-κB ↓ + TGF-β/SMAD ↓ + Nrf2 nephroprotection
⚠️ Always under the supervision of a nephrologist/endocrinologist
Discover INTI — 1.19g sugar
Related articles
Further reading on related topics :
- Dialysis & End-Stage Chronic Kidney Disease: Uremic NF-κB, RANKL and Microbiome | INTI Belgium
- Autoimmune Hepatitis (AIH) & Ginger: Hepatic NF-κB, Treg and Liver Microbiome | INTI Belgium
- Primary Biliary Cholangitis (PBC) & Ginger: Biliary NF-κB, Bile Acids and Hepatic Microbiome | INTI Belgium
- Dermatomyositis & Polymyositis: IFN-α, Muscular NF-κB, MDA5 and Microbiome | INTI Belgium
- cortisol-nfkb-gember-2025">Belgian Police Officers & Ginger: Chronic Stress, PTSD, ginger cortisol and NF-κB | INTI Belgium
- Psoriatic Arthritis & Ginger: IL-17A, TNF-α, ginger skin-Joint Axis and Microbiome | INTI Belgium
- POTS & Postural Dysautonomia: Autonomic NF-κB, RAAS and Microbiome | INTI Belgium
- Shift Workers & Ginger: BMAL1, Circadian Rhythm, Metabolism and NF-κB | INTI Belgium
Recommended pages
Explore more about INTI :